Medicine
Parsabiv 10 mg/2 mL injection
Parsabiv 10 mg/2 mL injection is a prescription medicine containing Etelcalcetide for intravenous use, marketed by Amgen, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians. It ships in a temperature-controlled cold chain.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Cold chain
Store in the original carton in refrigerator at 2°C to 8°C (36°F to 46°F) to…
Key facts
- Active ingredient (INN)
- Etelcalcetide
- Brand
- Parsabiv
- Strength
- 10 mg/2 mL
- Dosage form
- Injection
- Route
- Intravenous
- Packs
- 10 vials of 2 mL
- Marketing authorisation holder
- Amgen
- Manufacturer
- Amgen
- Origin register
- US FDA, United States
- Storage
- Store in the original carton in refrigerator at 2°C to 8°C (36°F to 46°F) to protect from light. Once removed from the refrigerator: Do not expose to temperatures above 25°C (77°F). Use within 7 days if stored in the original carton.
- Cold chain
- Yes, shipped temperature controlled
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- ATC code
- H05BX04 Etelcalcetide
- HS code (indicative)
- 3004.90Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 3 April 2017
- Identifiers
- RxCUI 1876127, 1876132, 1876135 +3DailyMed set ID cd270093-c6a8-4596-a4ab-e6aa0a2c8a0cNDC 55513-742Application NDA208325
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Other strengths and forms of Etelcalcetide
Clinical summary
Etelcalcetide is a calcium-sensing receptor agonist indicated for the treatment of secondary hyperparathyroidism (HPT) in adult patients with chronic kidney disease (CKD) on hemodialysis. It is available as injection for intravenous use. MedsAcross supplies Etelcalcetide for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about EtelcalcetideFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- PARSABIV prescribing information (Amgen) · U.S. National Library of Medicine, DailyMed
- Parsabiv: European public assessment report (EPAR) · European Medicines Agency
Need Parsabiv 10 mg/2 mL injection for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.